O23 Stock Overview
Develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for O23 from our risk checks.
ZimVie Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$8.10 |
| 52 Week High | US$20.00 |
| 52 Week Low | US$7.75 |
| Beta | 2 |
| 1 Month Change | -24.30% |
| 3 Month Change | -38.64% |
| 1 Year Change | -45.27% |
| 3 Year Change | -62.40% |
| 5 Year Change | n/a |
| Change since IPO | -62.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| O23 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.6% | 3.3% | 5.6% |
| 1Y | -45.3% | -19.5% | 4.8% |
Return vs Industry: O23 underperformed the German Medical Equipment industry which returned -21.1% over the past year.
Return vs Market: O23 underperformed the German Market which returned 2% over the past year.
Price Volatility
| O23 volatility | |
|---|---|
| O23 Average Weekly Movement | 6.5% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in DE Market | 12.5% |
| 10% least volatile stocks in DE Market | 3.0% |
Stable Share Price: O23 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: O23's weekly volatility (6%) has been stable over the past year.
Community vs My Fair Value
Select a narrative for quick price alerts from the community, or create your own.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2021 | 1,770 | Vafa Jamali | www.zimvie.com |
ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to support dental tooth replacement and restoration procedures worldwide. The company offers dental implant systems and biomaterials; digital dentistry solutions; restorative and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; intraoral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service.
ZimVie Inc. Fundamentals Summary
| O23 fundamental statistics | |
|---|---|
| Market cap | €224.35m |
| Earnings (TTM) | -€29.79m |
| Revenue (TTM) | €396.00m |
0.6x
P/S Ratio-7.8x
P/E RatioIs O23 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| O23 income statement (TTM) | |
|---|---|
| Revenue | US$449.75m |
| Cost of Revenue | US$162.30m |
| Gross Profit | US$287.45m |
| Other Expenses | US$321.28m |
| Earnings | -US$33.83m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.21 |
| Gross Margin | 63.91% |
| Net Profit Margin | -7.52% |
| Debt/Equity Ratio | 57.8% |
How did O23 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/14 05:57 |
| End of Day Share Price | 2025/04/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ZimVie Inc. is covered by 8 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Matthew Miksic | Barclays |
| Anderson Schock | B. Riley Securities, Inc. |
| Matthew Miksic | Credit Suisse |